Allos
A causal-AI platform for pharmaceutical process development, simulating how interventions…
A causal-AI platform for pharmaceutical process development, simulating how interventions affect outcomes before a single experiment runs. The site trades hype for evidence — every claim backed by a mechanism, a number, or an audit trail.
Homepage — the Allos platform, therapeutic outcomes, and system overview
Causal AI, not a GPT wrapper
The AI Platform page draws a hard line between Allos and generic AI tools upfront: purpose-built for process data, physics-informed and causality-aware models, human-in-the-loop decision making. Version control, traceability, and change management are shown as first-class product surfaces, not compliance afterthoughts — because the buyer here is validating whether they can trust the model's output, not just whether it works.
AI Platform — what makes Allos different, and how control is built in
Preserving causal intent from design to evidence
The Clinical Capabilities page extends the same causal framework from process development into clinical trial design — trial intent and estimand clarity, robust design under adaptation, patient stratification, and evidence integration. Each capability pairs its pitch with a named "AI advantage," translating a dense clinical-research concept into a concrete reason it beats the status quo.
Clinical Capabilities — trial design, stratification, and evidence integration
Compliance without black boxes
For a platform making decisions in regulated pharma environments, the Regulatory & Quality page is where trust actually gets earned: cGMP-compliant operations, 21 CFR Part 11 readiness, and ALCOA+ data integrity, each backed by a concrete artifact (audit trail, e-sign workflow, source-of-truth lineage) instead of a vague compliance badge.
Regulatory & Quality — cGMP, 21 CFR Part 11, and ALCOA+ data integrity
Our approach
Evidence over hype
Every section pairs its claim with a mechanism or a number — simulation-led experiments, quantified sensitivities, audit trails — never AI buzzwords standing alone.
One causal thread, three audiences
Process development, clinical trial design, and regulatory quality are presented as expressions of the same causal framework, not three disconnected feature sets.
Trust as the product
In a regulated, high-stakes domain, traceability and control aren't secondary features — they're given equal visual weight to the AI capability itself.
